Procrit Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified December 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2014 Category: Research Source Type: clinical trials

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2014 Category: Research Source Type: clinical trials

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified April 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2014 Category: Research Source Type: clinical trials

Long Term Extension Study for the Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified May 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 14, 2014 Category: Research Source Type: clinical trials

Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY 85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified October 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials

Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY 85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials

Maintenance Treatment of Anemia Associated With Chronic Kidney Disease (CKD) in Hemodialysis Subjects on Epoetin Alfa / Beta Treatment Versus BAY85-3934
Conditions:   Anemia;   Renal Insufficiency, ChronicInterventions:   Drug: Molidustat (BAY 85-3934);   Biological: Epoetin alfa/betaSponsor:   BayerRecruiting - verified March 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 18, 2013 Category: Research Source Type: clinical trials